# Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse

> **NCT01087008** · PHASE4 · COMPLETED · sponsor: **PETHEMA Foundation** · enrollment: 103 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** zoledronic acid
- **OTHER:** No treatment control

## Key facts

- **NCT ID:** NCT01087008
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-05
- **Final completion:** 2013-06-05
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2020-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01087008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01087008, "Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01087008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*